BI exec underscores what FDA approval of Spevigo means for GPP care

With approval in hand, Boehringer Ingelheim is now pivoting its efforts to educating patients, healthcare providers and prescribers as well as increasing awareness of GPP in general.

Related Keywords

Germany , German , Victoria Brown , Boehringer Ingelheim Spevigo , Bart Hess , Fashion Institute Of Technology , Drug Administration , Boehringer Ingelheim , Rare Disease Day , Fashion Institute , Unwearable Collection ,